1-7 of 7
Heidi Krause-Steinrauf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

52-OR: Emotional Distress and Insulin Initiation in the GRADE Trial

Free
CAROLINE A. PRESLEY, NICOLE M. BUTERA, HEIDI KRAUSE-STEINRAUF, CYRUS DESOUZA, PRISCILLA A. HOLLANDER, CLAIRE J. HOOGENDOORN, VIOLET LAGARI, ELIZABETH LEGOWSKI, CATHERINE MARTIN, NEDA RASOULI, JEFFREY S. GONZALEZ, ANDREA CHERRINGTON
Journal: Diabetes
Diabetes 2024;73(Supplement_1):52-OR
https://doi.org/10.2337/db24-52-OR
Published: 14 June 2024
View articletitled, 52-OR: Emotional Distress and Insulin Initiation in the GRADE Trial
Meeting Abstracts

220-OR: Characteristics Associated with Adding Insulin in Type 2 Diabetes in the Glycemia Reduction Approaches in Diabetes (GRADE) Study

Free
CATHERINE MARTIN, PRISCILLA A. HOLLANDER, HEIDI KRAUSE-STEINRAUF, ERIN KAZEMI, NICOLE M. BUTERA, ANDREW AHMANN, CORINNA FALCK-YTTER, BASMA FATTALEH, MARY L. JOHNSON, TINA KILLEAN, VIOLET LAGARI, MARY E. LARKIN, ELIZABETH LEGOWSKI, NEDA RASOULI, HOLLY WILLIS, GRADE RESEARCH GROUP
Journal: Diabetes
Diabetes 2022;71(Supplement_1):220-OR
https://doi.org/10.2337/db22-220-OR
Published: 01 June 2022
View articletitled, 220-OR: Characteristics Associated with Adding Insulin in Type 2 Diabetes in the Glycemia Reduction Approaches in Diabetes (GRADE) Study
Meeting Abstracts

1141-P: Detailed Phenotype of Randomized Participants by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Free
VANITA R. ARODA, HEIDI KRAUSE-STEINRAUF, JOHN B. BUSE, BARBARA I. GULANSKI, HERMES FLOREZ, ANDREW J. AHMANN, AMY LOVELAND, ALEXANDER KUHN, JACQUELINE LONIER, KIEREN J. MATHER, DEBORAH J. WEXLER, GRADE RESEARCH GROUP
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1141-P
https://doi.org/10.2337/db19-1141-P
Published: 01 June 2019
View articletitled, 1141-P: Detailed Phenotype of Randomized Participants by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
Meeting Abstracts

Risk Profiles for Microvascular and Macrovascular Disease at Baseline in the Glycemia Reduction Approaches in Diabetes—A Comparative Effectiveness (GRADE) Study

Free
KIEREN J. MATHER, RODICA POP-BUSUI, IONUT BEBU, CHELSEA BAKER, ROBERT M. COHEN, JILL P. CRANDALL, CYRUS DESOUZA, JENNIFER B. GREEN, M. SUE KIRKMAN, HEIDI KRAUSE-STEINRAUF, MARY E. LARKIN, JEREMY PETTUS, ELIZABETH R. SEAQUIST, ELSAYED Z. SOLIMAN, EMILY B. SCHROEDER, DEBORAH J. WEXLER, GRADE RESEARCH GROUP
Journal: Diabetes
Diabetes 2018;67(Supplement_1):187-LB
https://doi.org/10.2337/db18-187-LB
Published: 01 July 2018
View articletitled, Risk Profiles for Microvascular and Macrovascular Disease at Baseline in the Glycemia Reduction Approaches in Diabetes—A Comparative Effectiveness (GRADE) Study
Meeting Abstracts

Baseline Characteristics of Participants in the Glycemia Reduction Approaches in Diabetes—A Comparative Effectiveness Study (GRADE)

Free
DEBORAH J. WEXLER, HEIDI KRAUSE-STEINRAUF, ALEXANDER KUHN, JILL P. CRANDALL, HERMES FLOREZ, CHANTAL UNDERKOFLER, SOPHIA H. HOX, MICHAEL C. BACKMAN, VANITA ARODA, GRADE RESEARCH GROUP
Journal: Diabetes
Diabetes 2018;67(Supplement_1):1182-P
https://doi.org/10.2337/db18-1182-P
Published: 01 July 2018
View articletitled, Baseline Characteristics of Participants in the Glycemia Reduction Approaches in Diabetes—A Comparative Effectiveness Study (GRADE)
Journal Articles

Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data

Open Access
Carla J. Greenbaum, Craig A. Beam, David Boulware, Stephen E. Gitelman, Peter A. Gottlieb, Kevan C. Herold, John M. Lachin, Paula McGee, Jerry P. Palmer, Mark D. Pescovitz, Heidi Krause-Steinrauf, Jay S. Skyler, Jay M. Sosenko, on behalf of the Type 1 Diabetes TrialNet Study Group
Journal: Diabetes
Diabetes 2012;61(8):2066–2073
https://doi.org/10.2337/db11-1538
Published: 17 July 2012
View articletitled, Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data
Open the PDF for Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data in another window
Includes: Supplementary data
Journal Articles

Rituximab Selectively Suppresses Specific Islet Antibodies

Open Access
Liping Yu, Kevan Herold, Heidi Krause-Steinrauf, Paula L. McGee, Brian Bundy, Alberto Pugliese, Jeff Krischer, George S. Eisenbarth, for the Type 1 Diabetes TrialNet Anti-CD20 Study Group
Journal: Diabetes
Diabetes 2011;60(10):2560–2565
https://doi.org/10.2337/db11-0674
Published: 16 September 2011
View articletitled, Rituximab Selectively Suppresses Specific Islet Antibodies
Open the PDF for Rituximab Selectively Suppresses Specific Islet Antibodies in another window
Includes: Supplementary data